| scholarly article | Q13442814 |
| P50 | author | Michael A. Jarvis | Q42424922 |
| P2093 | author name string | Michael Mach | |
| William J Britt | |||
| Derek D Drummond | |||
| P2860 | cites work | Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing | Q27860941 |
| Folding and oligomerization of influenza hemagglutinin in the ER and the intermediate compartment. | Q27865300 | ||
| The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide | Q28646857 | ||
| Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes | Q30656734 | ||
| Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles | Q33784166 | ||
| Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B. | Q33793463 | ||
| Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. | Q42605806 | ||
| The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope | Q42615661 | ||
| Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein | Q42662287 | ||
| An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus | Q43700201 | ||
| Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization | Q45747539 | ||
| Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure | Q48258057 | ||
| Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion. | Q55472774 | ||
| Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells | Q64382797 | ||
| Inhibition of endoproteolytic cleavage of cytomegalovirus (HCMV) glycoprotein B by palmitoyl-peptidyl-chloromethyl ketone | Q68481623 | ||
| Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface | Q70147678 | ||
| The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond | Q73093769 | ||
| Effect of cysteine substitutions on dimerization and interfragment linkage of human cytomegalovirus glycoprotein B (gp UL55) | Q77692837 | ||
| Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment | Q33802787 | ||
| Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs | Q33870381 | ||
| A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus | Q33935010 | ||
| Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway | Q33957986 | ||
| Coding potential of laboratory and clinical strains of human cytomegalovirus | Q34388908 | ||
| Do pathogens accelerate atherosclerosis? | Q34389205 | ||
| Recombineering: a powerful new tool for mouse functional genomics | Q34389493 | ||
| Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: demonstration that pp28 (UL99) is essential for production of infectious virus. | Q34553401 | ||
| Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. | Q34858442 | ||
| Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. | Q35832875 | ||
| Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding | Q35850918 | ||
| Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain | Q35856690 | ||
| Proteins associated with purified human cytomegalovirus particles | Q35868126 | ||
| The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection | Q35887796 | ||
| Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers | Q36218773 | ||
| Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. | Q36295396 | ||
| Role of PACS-1 in Trafficking of Human Cytomegalovirus Glycoprotein B and Virus Production | Q36473935 | ||
| Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport | Q36632361 | ||
| Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies | Q36640712 | ||
| Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116) | Q36685373 | ||
| Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus | Q36687838 | ||
| Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays | Q36736217 | ||
| Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response | Q36802016 | ||
| Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. | Q36827278 | ||
| Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus | Q36861267 | ||
| Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome | Q37568012 | ||
| Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. | Q39577652 | ||
| Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. | Q39595874 | ||
| Disulfide bond configuration of human cytomegalovirus glycoprotein B. | Q39683804 | ||
| Disulfide bonds of herpes simplex virus type 2 glycoprotein gB. | Q39876716 | ||
| Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus | Q40887036 | ||
| Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion. | Q41171859 | ||
| Human cytomegalovirus glycoproteins | Q41454511 | ||
| Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus | Q41463497 | ||
| Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus | Q41597857 | ||
| Molecular domains involved in oligomerization of the Friend murine leukemia virus envelope glycoprotein | Q41653552 | ||
| P433 | issue | 7 | |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | 4066-4079 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B | |
| P478 | volume | 79 |
| Q37033353 | Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesis |
| Q24296677 | Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells |
| Q35139826 | Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms |
| Q54258038 | Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia. |
| Q36501775 | HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. |
| Q33572274 | HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation |
| Q21089588 | Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex |
| Q30831669 | Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes |
| Q36747999 | Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus |
| Q89489115 | Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model |
| Q39950845 | Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection |
| Q42147931 | Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus |
| Q54536982 | Sustained expression of human cytomegalovirus glycoprotein B (UL55) in the seeds of homozygous rice plants. |
| Q91853562 | The Human Cytomegalovirus Nonstructural Glycoprotein UL148 Reorganizes the Endoplasmic Reticulum |
| Q41832051 | The cytoplasmic tail of glycoprotein M (gpUL100) expresses trafficking signals required for human cytomegalovirus assembly and replication |
| Q36678423 | Update on the current status of cytomegalovirus vaccines |
Search more.